{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:24:00Z","timestamp":1791181440093,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.patbio.2004.02.007","type":"journal-article","created":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T05:20:36Z","timestamp":1080624036000},"page":"285-288","source":"Crossref","is-referenced-by-count":70,"title":["A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP)"],"prefix":"10.1016","volume":"52","author":[{"given":"Guido","family":"Finazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2004.02.007_BIB1","first-page":"202","article-title":"Indications for cytoreductive therapy in polycythemia vera and essential thrombocythemia","author":"Barbui","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.patbio.2004.02.007_BIB2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s002770050563","article-title":"Interferon \u03b1 in the treatment of polycythemia vera","volume":"79","author":"Lengfelder","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.patbio.2004.02.007_BIB3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90017-6","article-title":"Anagrelide, a therapy for thrombocythemic states: experience in 577\u00a0patients","volume":"92","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.patbio.2004.02.007_BIB4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.2002.03287.x","article-title":"The optimal management of polycythemia vera","volume":"116","author":"Spivak","year":"2002","journal-title":"Br J Hematol"},{"key":"10.1016\/j.patbio.2004.02.007_BIB5","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera: myths, mechanisms, and management","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2004.02.007_BIB6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.V99.4.1144","article-title":"The diagnosis and management of polycythemia vera in the era since the Policytemia Vera Study Group: a survey of American Society of Hematology members\u2019 practice 4\u00a0patterns","volume":"99","author":"Streiff","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2004.02.007_BIB7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2004.02.007_BIB8","first-page":"32a","article-title":"Morbidity and mortality of a multicountry prospective cohort of 1638\u00a0patients with polycythemia vera [Abstract]","volume":"102","author":"Marchioli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2004.02.007_BIB9","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1016\/j.patbio.2004.02.007_BIB10","first-page":"656","article-title":"Polycythemia vera: the natural history of 1213\u00a0patients followed over 20\u00a0years","volume":"123","year":"1995","journal-title":"Ann Int Med"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811404000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811404000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T05:24:24Z","timestamp":1550121864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811404000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0369811404000446"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2004.02.007","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}